[{"data":1,"prerenderedAt":-1},["ShallowReactive",2],{"health-study-detail:100596191":3},{"organization":4,"armGroups":7,"interventions":19,"overallOfficials":12,"centralContacts":25,"locations":31,"responsibleParty":45,"collaborators":47,"id":50,"slug":51,"hasResults":52,"nctId":53,"briefTitle":54,"officialTitle":55,"acronym":12,"eligibilityCriteria":56,"healthyVolunteers":52,"sex":57,"minAge":58,"maxAge":59,"enrollmentInfo":60,"targetDuration":12,"studyType":63,"phases":64,"briefSummary":66,"conditions":67,"keywords":82,"overallStatus":33,"whyStopped":12,"lastUpdateSubmitDate":88,"lastUpdatePostDateStruct":89,"startDateStruct":92,"completionDateStruct":94,"leadSponsor":96,"locationsCount":97},{"fullName":5,"class":6},"University of Florida","OTHER",[8,13],{"label":9,"type":10,"description":11,"interventionNames":12},"Participants receiving Standard care and MyCarePulse","NO_INTERVENTION","Participants not receiving the ASCENT Patient Navigator intervention, but are still utilizing MyCarePulse for comparison purposes. This arm will be conducted in phase 2 of the study and will have 50 participants (25 per site).",null,{"label":14,"type":15,"description":16,"interventionNames":17},"Participants receiving ASCENT Patient Navigator (PN) Intervention and MyCarePulse","EXPERIMENTAL","Participants will be receiving the ASCENT Patient Navigator intervention, and the MyCarePulse tool will flag participants who need assistance. They will then be connected to an ASCENT Patient Navigator to get those needs assessed. This arm will be conducted in phase 2 of the study and will have 50 participants (25 per site).",[18],"Behavioral: MyCarePulse and ASCENT PN",[20],{"type":21,"name":22,"description":23,"armGroupLabels":24,"otherNames":12},"BEHAVIORAL","MyCarePulse and ASCENT PN","The combination of a digital platform and patient navigators assisting the process. Also, taking a multi-level approach engaging community members, patients, and providers in phase one through qualitative interviews. Then using the findings to adapt MyCarePulse for the clincial trial in phase two.",[14],[26],{"name":27,"role":28,"phone":29,"phoneExt":12,"email":30},"Dejana Braithwaite, PhD, MSc","CONTACT","4152165093","dbraithwaite@surgery.ufl.edu",[32],{"facility":5,"status":33,"city":34,"state":35,"zip":36,"country":37,"countryCode":38,"cosmosGeoPoint":39,"geoPoint":44,"contacts":12},"RECRUITING","Gainesville","Florida","32610","United States","US",{"type":40,"coordinates":41},"Point",[42,43],-82.32483,29.65163,{"lat":43,"lon":42},{"type":46,"investigatorFullName":12,"investigatorTitle":12,"investigatorAffiliation":12,"oldNameTitle":12,"oldOrganization":12},"SPONSOR",[48],{"name":49,"class":6},"University of Miami","100596191","the-florida-ascent-study-100596191",false,"NCT07042243","The Florida ASCENT Study","The Florida Partnership for Adding Social Context to Address Cancer Survivorship Outcomes (Florida ASCENT)","Patient Eligibility Inclusion Criteria:\n\n1. ≥18 years old.\n2. Pathologically confirmed diagnosis of colorectal, prostate, lung, breast, gynecologic, hematologic, or skin (including melanoma) cancer within the past 12 months.\n3. Self-reported ability to read and speak English.\n4. Able to provide informed consent.\n5. Participant must not be considered a \"vulnerable population\" (pregnant women, neonates, children etc.)\n\nPatient Eligibility Exclusion Criteria:\n\n1. ≤18 years old.\n2. Participant do not have a pathologically confirmed diagnosis of colorectal, prostate, lung, breast, gynecologic, hematologic, or skin (including melanoma) cancer within the past 12 months.\n3. Participant does not live within the state of Florida.\n\n3\\) Does not self-reported ability to read and speak English or Spanish. 4) Not able to provide informed consent. 5) Participant is considered a \"vulnerable population\" (pregnant women, neonates, children etc.)\n\nProvider Eligibility Inclusion Criteria\n\n1. ≥18 years old.\n2. Currently works as a physician, physician assistant, patient navigator and\u002For health system\u002Fadministrative leader in UF and UM affiliated clinics.\n3. Self-reported ability to read and speak English or Spanish.\n4. Able to provide informed consent.\n5. Participant must not be considered a \"vulnerable population\" (pregnant women, neonates, children etc.)\n\nProvider Eligibility Exclusion Criteria\n\n1. ≤ 18 years old.\n2. Does not currently works as a physician, physician assistant, patient navigator and\u002For health system\u002Fadministrative leader in UF and UM affiliated clinics.\n3. Does not self-report having the ability to read and speak English.\n4. Not able to provide informed consent.\n5. Participant is considered a \"vulnerable population\" (pregnant women, neonates, children etc.)","ALL","18 Years","100 Years",{"count":61,"type":62},100,"ESTIMATED","INTERVENTIONAL",[65],"NA","The goal of this clinical trial is to adapt, implement, and evaluate MyCarePulse and ASCENT patient navigator to overcome barriers to care among patients with cancer.\n\nThe main hypotheses it aims to test are:\n\n* At the patient level, the intervention will result in higher levels of food security, self- efficacy for dietary behaviors, and higher diet quality than standard care.\n* At the provider level, the intervention will be feasible, acceptable, appropriate, and able to enhance individualized care for patient wellness.\n\nResearchers will compare cancer patients receiving the MyCarePulse and ASCENT patient navigator intervention to those receiving standard care, to see if the intervention improves food security, self-efficacy, and diet quality.\n\nPhase 1\n\nPatient Participants will:\n\n* Complete the ASCENT Questionnaire, which is comprised of the following:\n\n  * U.S. Food Security Survey Module (U.S. FSSM)\n  * Patient-Reported Outcomes Measurement Information System (PROMIS-29)\n  * Automated Self-Administered 24-Hour (ASA24®) Dietary Assessment Tool\n* Be assessed using the Veggie Meter instrument\n* Participate in two semi-structured interviews\n\nProvider Participants will:\n\n•Participate in one semi-structured interview\n\nPhase 2\n\nPatient Participants will:\n\n* Participate in ASCENT patient navigator screenings and consultations\n* Complete the ASCENT Questionnaire, which comprises the U.S. FSSM, PROMIS-29, and ASA24®",[68,69,70,71,72,73,74,75,76,77,78,79,80,81],"Cancer","Food Deprivation","Food Habits","Food Selection","Colorectal Cancer","Prostate Cancer","Lung Cancer","Breast Cancer","Gynecologic Cancer","Hematologic Cancer","Skin Cancer","Melanoma","Nutrition Poor","Nutritional Deficiency",[83,68,84,85,86,87],"Food Insecurity","Food Access","Community-Informed Research","Nutritional Needs","Mixed-Methods","2026-02-19",{"date":90,"type":91},"2026-02-20","ACTUAL",{"date":93,"type":91},"2025-12-05",{"date":95,"type":62},"2027-08",{"name":5,"class":6},1]